title: [Heparin-induced type II thrombocytopenia in intensive care].
authors.affiliation: Institut für Anästhesie, Deutsches Herzzentrum Berlin, Bundesrepublik Deutschland. Koster@dhzb.de
authors.forename: A
authors.initials: A
authors.lastname: Koster
authors.forename: O
authors.initials: O
authors.lastname: Meyer
authors.forename: M
authors.initials: M
authors.lastname: Kukucka
authors.forename: F
authors.initials: F
authors.lastname: Mertzlufft
authors.forename: H
authors.initials: H
authors.lastname: Kuppe
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D003422:Critical Care; D004305:Dose-Response Relationship, Drug; D006493:Heparin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D010976:Platelet Count; D012307:Risk Factors; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control; D013923:Thromboembolism / Q000139:chemically induced* / Q000175:diagnosis / Q000517:prevention & control
chemical_list: D000925:Anticoagulants; D006493:Heparin